Do you have difficulty sleeping at night, difficulty getting that
deep, restful sleep that makes you feel refreshed in the morning? If you have answered "yes" to one or more of these questions,
you may be suffering with a condition known as "fibromylagia."
Fibromylagia is a disorder often misdiagnosed by the majority of
medical practitioners. Most medical schools do not treat it as a real disease and medical
practitioners who do recognize it will often refer patients to their psychiatric
colleagues. It is sometimes known as "chronic fatigue syndrome," "chronic
myofascial pain syndrome" and other names. It is estimated that up to about 5-6% of
the population may suffer with this condition. It seems to primarily affect women,
although it certainly does affect men and even children.
The pain associated with fibromylagia can be limited or diffuse
(spread out). Patients complain of deep aching, throbbing, stabbing and shooting pains
throughout their body. There may be tingling and numbness in the extremities, as well as
frequent morning stiffness and increasing discomfort. The fatigue may be quite
overwhelming, to the point that it even interferes with the simplest daily activities.
Additionally, most people with fibromylagia have an associated
sleep disorder, which prevents them from getting a full, deep night of sleep. There are
other symptoms with fibromylagia, including migraine and irritable bowel syndrome. Many
complain of difficulties with their memory and concentration, skin sensitivities, or mood
swings. The cause of this ailment is not known. although it may well be a viral illness
that has eluded detection by the most skilled researchers. Also, because it is often
misdiagnosed as mental of psychological problem very little research has been conducted on
its origins. What is known is that its frequency is increasing, especially among those who
live in areas where environmental stress is evident.
The current edition of the Journal of Rheumatology International
has published a definitive answer to this question. The role of free radicals in
fibromylagia has often been a subject of scientific speculation. Now, in a study published
in this journal, 85 female patients with primary fibromylagia were matched with 80 healthy
women. Their oxidant/anti-oxidant balance was measured. There was a particular toxic
metabolite (a substance essential to the process in which energy is provided and new
material is created) called malondialdehyde, which is used as a marker for free radical
damage. Additionally, there is an enzyme called superoxide dismutase, which is a powerful
anti-oxidant. It was found that those women suffering with fibromylagia had significantly
higher levels of malondialdehyde and significantly lower levels of superoxide dismutase,
compared to the controlled subjects. The authors concluded that the oxidant/anti- oxidant
balances were changed in fibromylagia, and that free radical levels may be responsible for
the development of this condition.
The traditional treatment for fibromylagia in the United States
primarily involves the use of anti- depressants and strong antibiotics. Most people do not
respond well and their condition grows worse. Fortunately, there are several nutrients
that have been shown over the years to help reduce the symptoms and often lead to a
complete recovery. I
n one study, subjects were given oral doses of 200 mg of
co-enzyme Q10 and 200 mg of gingko biloba each day for twelve weeks. A progressive
improvement in the quality of life scores was observed over the course of the study. At
the end of the study, 64% of individuals reported that they were better, while only 9%
claimed that they felt worse.
In another study, 21 consecutive patients with fibromylagia were
included in an open four-week pilot study. These patients were given melatonin 3 mg at
bedtime. At the end of one month, patients reported a decrease in the number of tender
points and severity of pain, along with overall improvement in sleep. Although this was an
open study, the results suggest that melatonin may be an effective and safe treatment for
people with fibromylagia.
The mineral selenium has been studied in fibromylagia. In one
study from about five years ago, 68 consecutive patients with fibromylagia were matched
with 97 healthy controls. It was found that those patients suffering with fibromylagia had
a significantly decreased amount of selenium in their blood compared to the controlled
subjects. Selenium is renowned as a powerful anti-oxidant, and it is a co- factor for
certain anti-oxidant enzymes in the body. Without the addition of adequate selenium, these
enzymes cannot properly function.
Other nutrients that have shown some benefit for fibromylagia
include magnesium. The typical recommended dose of magnesium is 400-600 mg daily.
Finally, the most effective nutrient by far to be studied and the
most powerful is S-adenoslmethionine (otherwise known as SAMe). In one study published in
the Scandinavian Journal of Rheumatology, 800 mg of SAMe was administered daily, versus
placebo for 6 weeks in 44 patients with primary fibromylagia (double- blinded). At the end
of the study, there was a statistically significant improvement in pain, fatigue, morning
stiffness and mood in the treated group, compared to the placebo group.
Other nutrients that may be of significant help to people
suffering from fibromylagia or CFS include the high-energy producers Acetyl L-Carnitine
and Alpha Lipoic Acids. These powerful antioxidants are powerful anti-aging compounds as
well.